Los Angeles Capital Management LLC Sells 660 Shares of HealthEquity, Inc. $HQY

Los Angeles Capital Management LLC lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.6% in the second quarter, Holdings Channel reports. The firm owned 17,536 shares of the company’s stock after selling 660 shares during the period. Los Angeles Capital Management LLC’s holdings in HealthEquity were worth $1,837,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Nisa Investment Advisors LLC raised its position in shares of HealthEquity by 2.9% during the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after buying an additional 108 shares during the last quarter. Ieq Capital LLC increased its stake in HealthEquity by 4.4% during the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock valued at $260,000 after acquiring an additional 123 shares during the period. Xponance Inc. raised its holdings in HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company’s stock valued at $1,097,000 after acquiring an additional 136 shares in the last quarter. Sheets Smith Wealth Management lifted its position in shares of HealthEquity by 1.9% in the 2nd quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock worth $882,000 after acquiring an additional 157 shares during the period. Finally, Nordea Investment Management AB grew its holdings in shares of HealthEquity by 0.3% during the 2nd quarter. Nordea Investment Management AB now owns 59,732 shares of the company’s stock worth $6,319,000 after purchasing an additional 164 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 9,281 shares of company stock worth $859,867 in the last quarter. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

HQY has been the subject of a number of recent research reports. JPMorgan Chase & Co. upped their target price on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. KeyCorp lowered their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Royal Bank Of Canada upped their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, September 3rd. Finally, Barrington Research restated an “outperform” rating and set a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $121.31.

HealthEquity Price Performance

HQY stock opened at $99.83 on Wednesday. The stock has a market cap of $8.60 billion, a price-to-earnings ratio of 60.50, a P/E/G ratio of 1.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a 50 day simple moving average of $93.68 and a 200 day simple moving average of $95.75. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The firm had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.